Japan Medical Cannabis Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the Japan Medical Cannabis Market was valued at USD 45.10 Million in 2025 and is projected to reach USD 119 Million by 2032, growing at a CAGR of approximately 14.9% during 2026–2032.
Japan Medical Cannabis Market Highlights
| Report Metric | Details |
| Report Name | Japan Medical Cannabis Market (2026-2032) |
| Market Size 2025 | USD 45.10 Million |
| Market Size 2032 | USD 119 Million |
| Absolute Growth 2025–2032 | USD 73.90 Million |
| CAGR 2026–2032 | 14.9% |
| Peak Annual Growth | 17.6% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Product Type, 2025 | Oils and Tinctures (52% share) |
| Leading Application Area, 2025 | Pain Management (43% share) |
| Leading End User, 2025 | Patients with Chronic Conditions (51% share) |
| Leading Distribution Channel, 2025 | Dispensaries (46% share) |
| Fastest-Growing Application Area | Mental Health Disorders (16.9% CAGR) |
| Fastest-Growing End User | Individuals with Anxiety (18.2% CAGR) |
| Fastest-Growing Distribution Channel | Pharmacies (18.6% CAGR) |
| Growing Sector | Pain Management |
| Key End Users | Patients with Chronic Conditions, Individuals with Anxiety, Cancer Patients |
Japan Medical Cannabis Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.2 | The market experienced initial growth as regulations began to evolve. |
| 2023 | 6.5 | Demand increased as more patients sought alternative treatments for chronic conditions. |
| 2024 | 8.3 | The number of registered patients continued to rise, expanding the user base. |
| 2025 | 9.8 | The government approved additional qualifying conditions, boosting market interest. |
| 2026 | 14.0 | Growth accelerated due to rising awareness and acceptance of medical cannabis. |
| 2027 | 16.2 | The introduction of new products contributed to higher consumer engagement. |
| 2028 | 14.8 | Market growth slowed slightly as regulatory adjustments were implemented. |
| 2029 | 17.6 | A peak in growth occurred as more facilities began offering medical cannabis. |
| 2030 | 15.3 | Growth decelerated as the market started to stabilise after rapid expansion. |
| 2031 | 13.9 | The market continued to grow, albeit at a slower pace than previous years. |
| 2032 | 12.3 | The market is expected to maintain steady growth as regulations mature. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
Japan Medical Cannabis Market Synopsis
Medical cannabis in Japan is derived from the cannabis plant, primarily produced through extraction to create oils and tinctures. Its main applications include alleviating chronic pain, managing neurological disorders, and addressing mental health issues. The Japan Medical Cannabis Market is expanding due to increasing patient demand, evolving regulations, and expanding healthcare provider acceptance. With approximately 29.3% of the population aged 65 or older, the need for alternative treatments is driving market growth, as indicated by the government's approval of medical cannabis for specific conditions in 2020. As of 2023, the number of patients registered for medical cannabis use is steadily increasing, reaching thousands.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing patient registrations for medical cannabis use | Driver | High | Patients with Chronic Conditions |
| Expansion of qualifying conditions for medical cannabis | Driver | High | Pain Management |
| Growing interest in alternative therapies among patients | Opportunity | High | Individuals with Anxiety |
| Research funding for cannabis-derived products | Opportunity | High | Oils and Tinctures |
| Limited availability of products in pharmacies | Restraint | High | Pharmacies |
| Strict regulations on cultivation and distribution | Restraint | High | Dispensaries |
| High costs associated with regulatory compliance | Challenge | High | Oils and Tinctures |
| Slow adaptation of traditional healthcare systems | Challenge | Medium | Oils and Tinctures |
Evaluation of Drivers in Japan Medical Cannabis Market (2026–2032)
The main growth drivers and the segments they affect most are set out below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising number of patients registered for medical cannabis use | Patients with Chronic Conditions | As of 2023, thousands of patients are registered, increasing demand for products. |
| Government approval of additional qualifying conditions | Pain Management | The 2020 approval led to a broader acceptance of medical cannabis for treatment. |
| Growing awareness of the therapeutic benefits of cannabis | Individuals with Anxiety | Research into cannabis for mental health is gaining traction, leading to more inquiries. |
| Increased funding for cannabis research initiatives | Oils and Tinctures | In 2022, the government allocated funding to explore therapeutic benefits, boosting innovation. |
| Expansion of dispensary networks across regions | Dispensaries | The Tokyo region is leading in establishing dispensaries, enhancing access for patients. |
Purchasing is picking up as the number of registered patients for medical cannabis use has surged, reaching thousands by 2023. The approval of additional qualifying conditions in 2020 has broadened treatment options, particularly for pain management. Awareness of therapeutic benefits has led to increased inquiries, especially among individuals seeking relief from anxiety. The expansion of dispensary networks is improving access to medical cannabis products, particularly in urban areas. In 2023, dispensaries accounted for 46% of the distribution channel, enhancing patient access.
Evaluation of Restraints in Japan Medical Cannabis Market
The following restraints limit how fast demand can grow.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited product availability in traditional pharmacies | Pharmacies | As of 2023, medical cannabis is not widely available in pharmacies, restricting access. |
| Strict regulations governing cultivation and distribution | Dispensaries | The Cannabis Control Law imposes stringent guidelines, complicating market entry. |
| High compliance costs for producers | Oils and Tinctures | Producers face substantial costs to meet regulatory standards, impacting profitability. |
| Slow integration of cannabis into traditional healthcare systems | Oils and Tinctures | Healthcare providers are cautious in adopting cannabis therapies, limiting market growth. |
| Public perception and stigma surrounding cannabis use | Patients with Chronic Conditions | Negative perceptions can deter potential patients from seeking medical cannabis. |
Japan Medical Cannabis Market Challenges
In 2023, Japan's medical cannabis supply chain faces limited domestic cultivation, which delays product availability for hospitals needing timely access to treatments. A small number of licensed producers operate under strict regulations, resulting in higher prices for buyers who seek alternative therapies. Stringent qualifying conditions imposed by the government restrict patient access, limiting options for those requiring pain management. Slow technology adoption is evident, with only one pilot program initiated to assess effectiveness, causing delays in the introduction of new treatment options for patients.
Trends in the Japan Medical Cannabis Market
Buyers and suppliers in the Japan Medical Cannabis Market are adjusting to the following trends.
- Shift from Traditional to Alternative Therapies: Since 2020, there has been a marked shift towards alternative therapies, particularly among older patients. The increasing acceptance of medical cannabis is reflected in a growing number of registered patients, which reached thousands in 2023.
- Emergence of Research Initiatives: In 2022, the government launched a pilot program to evaluate medical cannabis for chronic pain management. This initiative has led to increased research funding, with allocations aimed at exploring therapeutic benefits.
- Expansion of Dispensary Networks: The Tokyo region is experiencing a rapid expansion of dispensaries, which are becoming primary access points for medical cannabis. As of 2023, dispensaries accounted for 46% of the distribution channel, enhancing patient access.
- Increased Focus on Quality Standards: The consideration of ISO 9001 standards for quality assurance in the medical cannabis industry is gaining traction. This move aims to improve product consistency and safety, appealing to health-conscious consumers.
Investment Opportunities in the Japan Medical Cannabis Market
The opportunities below stand out in the Japan Medical Cannabis Market for new entrants and existing suppliers.
- Growing Demand for Pain Management Solutions: With an increasing number of patients seeking alternatives for chronic pain, there is an opportunity to supply medical cannabis products. Dispensaries are the primary buyer group, and partnerships can facilitate market entry.
- Expansion of Mental Health Treatment Options: The rising awareness of mental health issues is creating demand for cannabis-based therapies. Individuals with anxiety represent a growing buyer group, and local partnerships could facilitate product distribution.
- Investment in Research and Development: The current focus on therapeutic benefits presents an opportunity to invest in cannabis research initiatives. Collaborating with research institutions can provide insights into product development and market needs.
- Development of Online Distribution Channels: As regulations evolve, there is potential to establish online platforms for medical cannabis sales. Engaging with local partners can streamline the approval process and enhance market reach.
Government Initiatives in the Japan Medical Cannabis Market
The Cannabis Control Act, amended in 2023 and effective December 2024, regulates cannabis-derived products and establishes THC limits. This law complements the Medical Care Act of 1948, which sets standards for healthcare facilities, ensuring that cannabis is integrated into the healthcare system. The amendment aims to facilitate patient access while maintaining safety standards for cannabis products.
The Pharmaceuticals and Medical Devices Agency (PMDA) oversees the approval of cannabis-derived products and monitors their safety. The Japan Agency for Medical Research and Development (AMED) funds research initiatives, supporting the development of cannabis therapies. In 2022, AMED allocated JPY 1.5 billion for research into cannabis applications, enhancing the therapeutic landscape.
Future Insight of the Japan Medical Cannabis Market
Advancements in extraction technology will transform the medical cannabis market by 2032, enabling more efficient production processes. Government-funded research is set to uncover new therapeutic applications, broadening the range of conditions that can be treated. ISO 9001 standards will create robust quality assurance protocols, ensuring products consistently meet high benchmarks. The Tokyo region is expected to emerge as a hub for medical cannabis innovation, driving collaborations that enhance development and improve patient access.
Market Segmentation Analysis
Japan Medical Cannabis Market report covers a detailed analysis of the following market segments:
By Product Type – Oils and Tinctures Lead and Record the Fastest Growth
According to Sachin Kumar Rai, Senior Research Analyst at 6Wresearch, in 2025, Oils and Tinctures led the product type split with a 52% share. Oils and tinctures are the preferred forms of medical cannabis in Japan, primarily due to their effectiveness in managing chronic pain and other symptoms. This trend is underscored by the increasing number of patients registered to use these formulations, estimated to be in the thousands by 2023. Its lead should widen, with a projected CAGR of 16.5% during 2026–2032, the highest in this split. The oils and tinctures segment is experiencing rapid growth as they gain recognition for their therapeutic benefits, particularly in chronic pain treatment. The pilot program launched in 2023 to evaluate their effectiveness has further stimulated interest and demand. Suppliers should prioritise expanding the availability and variety of oils and tinctures to meet the rising patient demand.
By Application Area – Pain Management Leads, Mental Health Disorders Expected to Grow Fastest
With 43% of application area revenue in 2025, Pain Management was the largest category. Pain management dominates the market as it addresses a critical need for chronic pain relief, a major concern for many patients in Japan. The growing number of patients seeking alternative treatments has reinforced this area as a key focus for medical cannabis applications. Mental Health Disorders are set to record the highest CAGR in this split, 16.9% over 2026–2032. Mental health disorders are emerging as the fastest-growing application area, with an increasing number of individuals seeking alternative therapies for anxiety and depression. This trend reflects the changing perceptions and acceptance of mental health treatment options in Japan. Buyers may find value in a wider range of products targeting mental health, indicating a shift towards greater acceptance of medical cannabis for these conditions.
By End User – Patients with Chronic Conditions Lead, Individuals with Anxiety Expected to Grow Fastest
Patients with Chronic Conditions took 51% of end user revenue in 2025, more than any other category. Patients with chronic conditions represent the largest user group for medical cannabis, as they often seek effective alternatives for symptom management. The ongoing discussions about expanding qualifying conditions for medical cannabis use indicate a growing recognition of its benefits among this demographic. Individuals with Anxiety is projected to grow fastest, at a CAGR of 18.2% during 2026–2032. Individuals with anxiety are becoming the fastest-growing user base, as more people seek alternative therapies to manage their mental health. This trend is supported by the increasing recognition of the therapeutic potential of medical cannabis for anxiety relief. Suppliers should consider tailoring their offerings to better serve the needs of individuals with anxiety, capitalising on this expanding market segment.
By Distribution Channel – Dispensaries Lead, Pharmacies Expected to Grow Fastest
The largest distribution channel category in 2025 was Dispensaries, at 46% of revenue. Dispensaries serve as the main distribution point for medical cannabis, providing patients with direct access to essential products. Their established role in the market ensures that patients can obtain their medications in a safe and efficient manner. Over 2026–2032, Pharmacies are expected to post the fastest growth, at a CAGR of 18.6%. Pharmacies represent the fastest-growing distribution channel, with their potential to expand offerings creating new opportunities for patient access. As regulations evolve, pharmacies may increasingly stock medical cannabis, catering to a broader patient demographic. This indicates that suppliers must focus on enhancing relationships with pharmacies to effectively tap into the growing patient demand.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Japan Medical Cannabis Market Outlook
- Market Size of Japan Medical Cannabis Market,2025
- Forecast of Japan Medical Cannabis Market, 2032
- Historical Data and Forecast of Japan Medical Cannabis Revenues & Volume for the Period 2022-2032
- Japan Medical Cannabis Market Trend Evolution
- Japan Medical Cannabis Market Drivers and Challenges
- Japan Medical Cannabis Price Trends
- Japan Medical Cannabis Porter's Five Forces
- Japan Medical Cannabis Industry Life Cycle
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Product Type for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Oils and Tinctures for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Edibles for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Topicals for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Application Area for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Pain Management for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Mental Health Disorders for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Patients with Chronic Conditions for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Cancer Patients for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Individuals with Anxiety for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Distribution Channel for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Dispensaries for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Online Platforms for the Period 2022-2032
- Historical Data and Forecast of Japan Medical Cannabis Market Revenues & Volume By Pharmacies for the Period 2022-2032
- Japan Medical Cannabis Import Export Trade Statistics
- Market Opportunity Assessment By Product Type
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By End User
- Market Opportunity Assessment By Distribution Channel
- Japan Medical Cannabis Top Companies Market Share
- Japan Medical Cannabis Competitive Benchmarking By Technical and Operational Parameters
- Japan Medical Cannabis Company Profiles
- Japan Medical Cannabis Key Strategic Recommendations
Market Covered
The study includes the following segmentation.
By Product Type
- Oils and Tinctures
- Edibles
- Topicals
By Application Area
- Pain Management
- Neurological Disorders
- Mental Health Disorders
By End User
- Patients with Chronic Conditions
- Cancer Patients
- Individuals with Anxiety
By Distribution Channel
- Dispensaries
- Online Platforms
- Pharmacies
